JAMES M. FRATES - Chief Financial Officer at Amylyx Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Issuer Symbol
AMLX on Nasdaq
All Insider Reports
All Insider Reports

JAMES M. FRATES - trading volume in the past year for Amylyx Pharmaceuticals, Inc.

Holdings reported by JAMES M. FRATES for Amylyx Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 280,430 $4,107,654 $14.65 30 Sep 2025 Direct
Common Stock 11,072 $108,948 $9.84 30 Sep 2025 By Trust
Stock Option (right to buy) 102,630 06 Mar 2025 Direct Common Stock

Transactions reported by JAMES M. FRATES for Amylyx Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.